News Quantified

AMPH – amphastar pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026 [Yahoo! Finance]

Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Mixed Recent Share Performance [Yahoo! Finance]

Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know [Yahoo! Finance]

2 Reasons to Avoid AMPH and 1 Stock to Buy Instead [Yahoo! Finance]

Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving [Yahoo! Finance]

-0.8%

BEAT

8.2%

BEAT

0.9%

BEAT

0.9%

BEAT

Form 8-K Amphastar Pharmaceutical For: Jan 06

Form 4 Amphastar Pharmaceutical For: Dec 17 Filed by: Zhou Rong

Form 4 Amphastar Pharmaceutical For: Dec 11 Filed by: Petersen Floyd F.

Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F.

Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F.

Top News Gainers

3/16 Form 10-K Amphastar Pharmaceutical For: Dec 31 11.3%

4/27 Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial 7.5%

8/7 Q2/2019 6/30/2019 EPS 0.080 ZacksConsensus 0.030 ActVsEst 0.050 - Beat 7.0%

11/8 Amphastar Pharmaceuticals Inc (AMPH) Q3 2019 Earnings Call Transcript [The Motley Fool] 4.9%

3/18 Form 4 Amphastar Pharmaceutical For: Mar 16 Filed by: Liawatidewi Yakob 4.5%

3/3 Form 4 Amphastar Pharmaceutical For: Mar 02 Filed by: Petersen Floyd F. 3.9%

4/9 Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference 3.8%

8/16 Form 4 Amphastar Pharmaceutical For: Aug 15 Filed by: PETERS WILLIAM J 3.4%

9/9 Form 4 Amphastar Pharmaceutical For: Sep 05 Filed by: Liawatidewi Yakob 3.1%

3/12 Q4/2019 12/31/2019 EPS 0.070 ZacksConsensus 0.050 ActVsEst 0.020 - Beat 2.3%

Top News Decliners

3/17 Form 4 Amphastar Pharmaceutical For: Mar 15 Filed by: Zhou Rong -11.9%

3/12 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -9.3%

2/28 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -9.3%

3/13 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $16.00 price target on the stock. -8.2%

11/7 Form 8-K Amphastar Pharmaceutical For: Nov 07 -8.0%

5/31 Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference -7.3%

5/12 Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -6.8%

11/8 Form 10-Q Amphastar Pharmaceutical For: Sep 30 -5.8%

1/29 Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) had its "hold" rating re-affirmed by analysts at Needham & Company LLC. -3.1%

6/10 Form 4 Amphastar Pharmaceutical For: Jun 07 Filed by: Lee Howard -3.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day